151 related articles for article (PubMed ID: 35489353)
1. Imaging response assessment for CNS germ cell tumours: consensus recommendations from the European Society for Paediatric Oncology Brain Tumour Group and North American Children's Oncology Group.
Morana G; Shaw D; MacDonald SM; Alapetite C; Ajithkumar T; Bhatia A; Brisse H; Jaimes C; Czech T; Dhall G; Fangusaro J; Faure-Conter C; Fouladi M; Hargrave D; Harreld JH; Mitra D; Nicholson JC; Souweidane M; Timmermann B; Calaminus G; Bartels U; Bison B; Murray MJ
Lancet Oncol; 2022 May; 23(5):e218-e228. PubMed ID: 35489353
[TBL] [Abstract][Full Text] [Related]
2. Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Fangusaro J; Witt O; Hernáiz Driever P; Bag AK; de Blank P; Kadom N; Kilburn L; Lober RM; Robison NJ; Fisher MJ; Packer RJ; Young Poussaint T; Papusha L; Avula S; Brandes AA; Bouffet E; Bowers D; Artemov A; Chintagumpala M; Zurakowski D; van den Bent M; Bison B; Yeom KW; Taal W; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e305-e316. PubMed ID: 32502457
[TBL] [Abstract][Full Text] [Related]
3. Consensus on the management of intracranial germ-cell tumours.
Murray MJ; Bartels U; Nishikawa R; Fangusaro J; Matsutani M; Nicholson JC
Lancet Oncol; 2015 Sep; 16(9):e470-e477. PubMed ID: 26370356
[TBL] [Abstract][Full Text] [Related]
4. Response assessment in paediatric intracranial ependymoma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lindsay HB; Massimino M; Avula S; Stivaros S; Grundy R; Metrock K; Bhatia A; Fernández-Teijeiro A; Chiapparini L; Bennett J; Wright K; Hoffman LM; Smith A; Pajtler KW; Poussaint TY; Warren KE; Foreman NK; Mirsky DM
Lancet Oncol; 2022 Aug; 23(8):e393-e401. PubMed ID: 35901835
[TBL] [Abstract][Full Text] [Related]
5. European Society for Paediatric Oncology (SIOPE) MRI guidelines for imaging patients with central nervous system tumours.
Avula S; Peet A; Morana G; Morgan P; Warmuth-Metz M; Jaspan T;
Childs Nerv Syst; 2021 Aug; 37(8):2497-2508. PubMed ID: 33973057
[TBL] [Abstract][Full Text] [Related]
6. Rare embryonal and sarcomatous central nervous system tumours: State-of-the art and future directions.
Gojo J; Kjaersgaard M; Zezschwitz BV; Capper D; Tietze A; Kool M; Haberler C; Pizer B; Hoff KV
Eur J Med Genet; 2023 Jan; 66(1):104660. PubMed ID: 36356895
[TBL] [Abstract][Full Text] [Related]
7. Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Erker C; Tamrazi B; Poussaint TY; Mueller S; Mata-Mbemba D; Franceschi E; Brandes AA; Rao A; Haworth KB; Wen PY; Goldman S; Vezina G; MacDonald TJ; Dunkel IJ; Morgan PS; Jaspan T; Prados MD; Warren KE
Lancet Oncol; 2020 Jun; 21(6):e317-e329. PubMed ID: 32502458
[TBL] [Abstract][Full Text] [Related]
8. Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe.
Hettmer S; Linardic CM; Kelsey A; Rudzinski ER; Vokuhl C; Selfe J; Ruhen O; Shern JF; Khan J; Kovach AR; Lupo PJ; Gatz SA; Schäfer BW; Volchenboum S; Minard-Colin V; Koscielniak E; Hawkins DS; Bisogno G; Sparber-Sauer M; Venkatramani R; Merks JHM; Shipley J
Eur J Cancer; 2022 Sep; 172():367-386. PubMed ID: 35839732
[TBL] [Abstract][Full Text] [Related]
9. Symptom interval and treatment burden for patients with malignant central nervous system germ cell tumours.
Hayden J; Murray MJ; Bartels U; Ajithkumar T; Muthusamy B; Penn A; Calaminus G; Nicholson J
Arch Dis Child; 2020 Mar; 105(3):247-252. PubMed ID: 31594777
[TBL] [Abstract][Full Text] [Related]
10. Automated quantitative tumour response assessment of MRI in neuro-oncology with artificial neural networks: a multicentre, retrospective study.
Kickingereder P; Isensee F; Tursunova I; Petersen J; Neuberger U; Bonekamp D; Brugnara G; Schell M; Kessler T; Foltyn M; Harting I; Sahm F; Prager M; Nowosielski M; Wick A; Nolden M; Radbruch A; Debus J; Schlemmer HP; Heiland S; Platten M; von Deimling A; van den Bent MJ; Gorlia T; Wick W; Bendszus M; Maier-Hein KH
Lancet Oncol; 2019 May; 20(5):728-740. PubMed ID: 30952559
[TBL] [Abstract][Full Text] [Related]
11. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study.
Khan S; Solano-Paez P; Suwal T; Lu M; Al-Karmi S; Ho B; Mumal I; Shago M; Hoffman LM; Dodgshun A; Nobusawa S; Tabori U; Bartels U; Ziegler DS; Hansford JR; Ramaswamy V; Hawkins C; Dufour C; André N; Bouffet E; Huang A;
Lancet Child Adolesc Health; 2021 Nov; 5(11):800-813. PubMed ID: 34599879
[TBL] [Abstract][Full Text] [Related]
12. RAPNO efforts in Brain Tumour Outcomes.
Virani QU; Javed Z; Shamim MS
J Pak Med Assoc; 2024 May; 74(5):1005-1006. PubMed ID: 38783459
[TBL] [Abstract][Full Text] [Related]
13. Paediatric germ cell tumours of the central nervous system: Results and experience from a tertiary-referral paediatric institution in Australia.
Carlos Chung KH; Owler BK; Dexter M; Chaseling R
J Clin Neurosci; 2013 Apr; 20(4):514-9. PubMed ID: 23317752
[TBL] [Abstract][Full Text] [Related]
14. The treatment of cranial germ cell tumours.
Brandes AA; Pasetto LM; Monfardini S
Cancer Treat Rev; 2000 Aug; 26(4):233-42. PubMed ID: 10913379
[TBL] [Abstract][Full Text] [Related]
15. Paediatric extracranial germ-cell tumours.
Shaikh F; Murray MJ; Amatruda JF; Coleman N; Nicholson JC; Hale JP; Pashankar F; Stoneham SJ; Poynter JN; Olson TA; Billmire DF; Stark D; Rodriguez-Galindo C; Frazier AL
Lancet Oncol; 2016 Apr; 17(4):e149-e162. PubMed ID: 27300675
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of treatment response using integrated 18F-labeled choline positron emission tomography/magnetic resonance imaging in adolescents with intracranial non-germinomatous germ cell tumours.
Tsouana E; Stoneham S; Fersht N; Kitchen N; Gaze M; Bomanji J; Fraioli F; Hargrave D; Shankar A
Pediatr Blood Cancer; 2015 Sep; 62(9):1661-3. PubMed ID: 25854508
[TBL] [Abstract][Full Text] [Related]
17. [Intracranial germ cell tumours: A 21-year review].
Cormenzana Carpio M; Nehme Álvarez D; Hernández Marqúes C; Pérez Martínez A; Lassaletta Atienza A; Madero López L
An Pediatr (Barc); 2017 Jan; 86(1):20-27. PubMed ID: 27068071
[TBL] [Abstract][Full Text] [Related]
18. Positron emission tomography in the diagnosis and management of intracranial germ cell tumours.
Kelly PA; Metcalfe K; Evanson J; Sabin I; Plowman PN; Monson JP
Horm Res; 2009; 72(3):190-6. PubMed ID: 19729952
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and risk factors for cisplatin-induced hearing loss in children, adolescents, and young adults: a multi-institutional North American cohort study.
Moke DJ; Luo C; Millstein J; Knight KR; Rassekh SR; Brooks B; Ross CJD; Wright M; Mena V; Rushing T; Esbenshade AJ; Carleton BC; Orgel E
Lancet Child Adolesc Health; 2021 Apr; 5(4):274-283. PubMed ID: 33581749
[TBL] [Abstract][Full Text] [Related]
20. Primary intracranial germ cell tumours: experience of a single South-East Asian institution.
Foo AS; Lim C; Chong DQ; Tan DY; Tham CK
J Clin Neurosci; 2014 Oct; 21(10):1761-6. PubMed ID: 24954243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
